Results 341 to 350 of about 9,268,601 (369)
Some of the next articles are maybe not open access.

Related searches:

Neurodegenerative Diseases

Radiologic Clinics of North America, 2008
This article outlines the changes seen using various imaging modalities in the normally aging brain and then discusses in detail the changes seen with various pathologic conditions. Entities discussed include primary degenerative dementias, extrapyramidal system diseases, and vascular dementias.
Gallucci M.   +3 more
openaire   +3 more sources

SUMOylation in Neurodegenerative Diseases

Gerontology, 2019
Posttranslational modifications are ubiquitous regulators of cellular processes. The regulatory role of SUMOylation, the attachment of a small ubiquitin-related modifier to a target protein, has been implicated in fundamental processes like cell division, DNA damage repair, mitochondrial homeostasis, and stress responses.
Princz, Andrea, Tavernarakis, Nektarios
openaire   +2 more sources

Microbiota and neurodegenerative diseases

Current Opinion in Neurology, 2017
Purpose of review Despite the extensive research carried out in the past decades, the current pathophysiological notions of neurodegenerative disease as well as effective treatments to reduce their progression are largely unknown. Alterations of the human microbiota, the plethora of different microscopic organisms that our body
Marizzoni, Moira   +3 more
openaire   +4 more sources

Oxysterols and neurodegenerative diseases

Molecular Aspects of Medicine, 2009
In contrast to their parent molecule cholesterol, two of its side-chain oxidized metabolites are able to cross the blood-brain barrier. There is a concentration-driven flux of 24S-hydroxycholesterol (24S-OHC) from the brain into the circulation, which is of major importance for elimination of excess cholesterol from the brain.
Björkhem I   +3 more
openaire   +3 more sources

Neuroprotection and Neurodegenerative Disease

Journal of Clinical Neuroscience, 2002
This paper will focus on commonalities in the aetiology and pathology in five areas of neurological disease with illustrative examples of therapy. Possibilities of multimodal and neuroprotective therapies in human disease, employing currently available drugs and showing evidence of neuroprotective potential in animal models, are discussed.
openaire   +3 more sources

Home - About - Disclaimer - Privacy